Guhlich Manuel, Maag Teresa Esther, Schirmer Markus Anton, Chacón Quesada Tatiana Andrea, Mielke Dorothee, Rieken Stefan, Leu Martin, Dröge Leif Hendrik
Clinic of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Quality Conferences Office at the Clinical State Registry Baden-Württemberg GmbH, Baden-Württemberg Cancer Registry (BWCR), Stuttgart, Germany.
BMC Cancer. 2025 Apr 23;25(1):759. doi: 10.1186/s12885-025-14106-y.
Malignant spinal cord compression (MSCC) can lead to immediate neurological impairment. In order to preserve and, optimally, restore neurological functions, urgent treatment (usually, within 24 h) is necessary. Treatment options mainly consist of decompressive surgery (DS) and / or radiotherapy (RT) combined with steroids. Whereas historically, RT was the treatment of choice, DS has become standard of care, where applicable. Despite a variety of excellent studies, real world data of treatment in a large academic center is currently underrepresented. We performed a retrospective analysis of patients treated for MSCC in our department of radiotherapy between 1998 and 2018 (n = 131), evaluating treatment, achievement of clinically determined improvement of neurological functions as well as overall survival (OS) and treatment-related toxicity. Kaplan-Meier estimator was used for survival statistics, log rank test for survival time comparisons, univariable and multivariable Cox regression and logistic regression for assessing potential impacts of variables on survival and symptom relief. 42.7% of patients had DS before RT (n = 56), 57.3% (n = 75) received RT without DS. Symptom relief was achieved in 41.2% of all patients (n = 54, n = 26 of those had DS before RT, p = 0.12). RT completed as intended (p < 0.001) was statistically significant for symptom relief, wherein symptom relief (p < 0.001), completion of RT course as intended (p = 0.01) and more recent treatment dates (p = 0.002) were independent predictors for OS. We herein present a large cohort of patients treated for MSCC in our academic center, representing real world treatment data currently lacking in literature.
恶性脊髓压迫症(MSCC)可导致即刻神经功能损害。为了保留并尽可能恢复神经功能,需要进行紧急治疗(通常在24小时内)。治疗选择主要包括减压手术(DS)和/或放疗(RT)联合使用类固醇。从历史上看,放疗是首选治疗方法,但在适用的情况下,减压手术已成为标准治疗方法。尽管有大量出色的研究,但大型学术中心治疗的真实世界数据目前仍未得到充分体现。我们对1998年至2018年间在我们放疗科接受MSCC治疗的患者进行了回顾性分析(n = 131),评估了治疗情况、临床确定的神经功能改善情况以及总生存期(OS)和治疗相关毒性。采用Kaplan-Meier估计器进行生存统计,采用对数秩检验进行生存时间比较,采用单变量和多变量Cox回归以及逻辑回归评估变量对生存和症状缓解的潜在影响。42.7%的患者在放疗前接受了减压手术(n = 56),57.3%(n = 75)的患者接受了未进行减压手术的放疗。所有患者中有41.2%(n = 54)实现了症状缓解(其中26例在放疗前接受了减压手术,p = 0.12)。按计划完成放疗(p < 0.001)对症状缓解具有统计学意义,其中症状缓解(p < 0.001)、按计划完成放疗疗程(p = 0.01)和更近的治疗日期(p = 0.002)是总生存期的独立预测因素。我们在此展示了在我们学术中心接受MSCC治疗的一大群患者,代表了目前文献中缺乏的真实世界治疗数据。